WO2024055835A1 - 一种解酒护肝饮品及其制备方法 - Google Patents
一种解酒护肝饮品及其制备方法 Download PDFInfo
- Publication number
- WO2024055835A1 WO2024055835A1 PCT/CN2023/115306 CN2023115306W WO2024055835A1 WO 2024055835 A1 WO2024055835 A1 WO 2024055835A1 CN 2023115306 W CN2023115306 W CN 2023115306W WO 2024055835 A1 WO2024055835 A1 WO 2024055835A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- parts
- liver
- hangover
- relieving
- drink
- Prior art date
Links
- 206010019133 Hangover Diseases 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 235000013361 beverage Nutrition 0.000 title abstract description 4
- 238000011049 filling Methods 0.000 claims abstract description 17
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 16
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 16
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000000855 fermentation Methods 0.000 claims abstract description 15
- 230000004151 fermentation Effects 0.000 claims abstract description 15
- 230000001954 sterilising effect Effects 0.000 claims abstract description 15
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 15
- 239000011550 stock solution Substances 0.000 claims abstract description 11
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 8
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 8
- 229960000304 folic acid Drugs 0.000 claims abstract description 8
- 235000019152 folic acid Nutrition 0.000 claims abstract description 8
- 239000011724 folic acid Substances 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 8
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 8
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 8
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 8
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 8
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000811 xylitol Substances 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 8
- 229960002675 xylitol Drugs 0.000 claims abstract description 8
- 235000010447 xylitol Nutrition 0.000 claims abstract description 8
- 238000001816 cooling Methods 0.000 claims abstract description 3
- 244000157072 Hylocereus undatus Species 0.000 claims description 24
- 235000018481 Hylocereus undatus Nutrition 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 10
- 238000000265 homogenisation Methods 0.000 claims description 9
- 241000405398 Hovenia Species 0.000 claims description 7
- 235000008586 Hovenia Nutrition 0.000 claims description 7
- 239000012856 weighed raw material Substances 0.000 claims description 7
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract description 6
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 abstract description 3
- 229940107187 fructooligosaccharide Drugs 0.000 abstract description 3
- 244000010000 Hovenia dulcis Species 0.000 abstract description 2
- 235000008584 Hovenia dulcis Nutrition 0.000 abstract description 2
- 240000009012 Hylocereus polyrhizus Species 0.000 abstract 1
- 238000002372 labelling Methods 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 57
- 235000019441 ethanol Nutrition 0.000 description 44
- 210000004185 liver Anatomy 0.000 description 19
- 238000002474 experimental method Methods 0.000 description 18
- 230000004060 metabolic process Effects 0.000 description 16
- 230000035622 drinking Effects 0.000 description 14
- 230000000694 effects Effects 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000008280 blood Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 235000021391 short chain fatty acids Nutrition 0.000 description 6
- 150000004666 short chain fatty acids Chemical class 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 102000005962 receptors Human genes 0.000 description 5
- 108020003175 receptors Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 5
- 102100040133 Free fatty acid receptor 2 Human genes 0.000 description 4
- 102100040136 Free fatty acid receptor 3 Human genes 0.000 description 4
- 101000890668 Homo sapiens Free fatty acid receptor 2 Proteins 0.000 description 4
- 101000890662 Homo sapiens Free fatty acid receptor 3 Proteins 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 210000005229 liver cell Anatomy 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 208000007848 Alcoholism Diseases 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 201000007930 alcohol dependence Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000003238 somatosensory effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 238000013475 authorization Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 235000020068 maotai Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000007102 metabolic function Effects 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 238000011514 vinification Methods 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000010837 Echinocereus enneacanthus subsp brevispinus Nutrition 0.000 description 1
- 235000006850 Echinocereus enneacanthus var dubius Nutrition 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000004149 ethanol metabolism Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the invention belongs to the technical field of functional food, and in particular relates to a hangover-relieving and liver-protecting drink and a preparation method thereof.
- liver is one of the most important organs of the human body, and it must maintain its normal function. It is the main indicator for human body to maintain health.
- liver cell membranes damage to liver cell membranes.
- Toxicity such as peroxidation of lipids on the surface of liver cell membranes and damage to liver cell membranes.
- Long-term drinking can also damage structures such as microtubules and mitochondria in liver cells, disrupt intracellular metabolism, and produce cytotoxic metabolites. , leading to liver cell swelling, necrosis, etc.
- the purpose of the present invention is to provide a method for preparing a dragon fruit fermentation hangover drink that helps accelerate the body's alcohol metabolism and protects the liver.
- This drink uses dragon fruit fermentation liquid as the The main function is to play a synergistic effect when combined with medicinal and edible foods, including Pueraria lobata, Hovenia truncatula extract and complex nutritional fortifiers as auxiliary ingredients. It has an obvious hangover effect, good liver protection effect, and can also regulate its own metabolic function.
- the technical solution adopted by the present invention is as follows: 30 to 60 parts of red dragon fruit fermentation stock solution, 30 to 60 parts of fructooligosaccharide, 20 to 30 parts of xylitol, 20 to 30 parts of kudzu root extract, and 20 to 30 parts of Hovenia truncatula extract. part, nicotinamide 0.5*10 -4 ⁇ 1.0*10 -4 part, vitamin B12 0.5*10 -6 ⁇ 1.0*10 -6 part, vitamin B6 0.1*10 -4 ⁇ 0.5*10 -4 part, folic acid 0.1* 10 -5 ⁇ 0.5*10 -5 parts, 600 ⁇ 800 parts of water.
- a method for preparing a hangover-relieving and liver-protecting drink of the present invention includes the following steps:
- Step 1 Weigh the raw materials of the corresponding components by weight, place the weighed raw materials in the batching tank and homogenize to obtain a homogenized mixed solution;
- Step 2 The homogenized mixed liquid is pumped into the automatic filling equipment, and is rolled and sealed after filling to obtain a finished product that is rolled and sealed after filling;
- Step 3 Send the filled, capped and sealed finished product into the microwave sterilization equipment for microwave sterilization. After cooling to normal temperature, it is labeled, coded and packaged to obtain a hangover-relieving and liver-protecting drink.
- step one the temperature during homogenization in step one is 55 ⁇ 60°C, and the homogenization time is 1.5 ⁇ 2h.
- the authorization announcement number of the preparation method of the red dragon fruit fermentation stock solution is CN108402454B.
- the tricarboxylic acid cycle is a ubiquitous metabolic pathway in aerobic organisms. It is distributed in mitochondria and is the final metabolic pathway for the three major nutrients, sugars, lipids, and amino acids. It has important physiological significance for organisms. Research has found that citric acid, succinic acid, malic acid, pyruvate and other short-chain fatty acids are process substances in the tricarboxylic acid cycle, directly participating in and accelerating the operation of the tricarboxylic acid cycle, thereby improving the body's basal metabolic capacity and playing a role in Accelerates alcohol metabolism.
- GPR41 and GPR43 the only two specific short-chain fatty acid receptors that have been discovered so far are GPR41 and GPR43.
- these two receptors have become an important target for drug screening.
- the liver is often overloaded.
- the dragon fruit fermentation liquid is rich in acetic acid, propionic acid, butyric acid, valeric acid and other short-chain fatty acids that can activate GPR41 and GPR43 receptors, thereby reducing liver function. load and play a role in protecting the liver.
- the preparation method of the red dragon fruit fermentation stock solution has applied for a patent, and the authorization announcement number is: CN108402454B.
- Dragon fruit fermentation stock solution is rich in a variety of short-chain fatty acids, which can activate specific G protein-coupled receptors such as FFA2R and FFA3R (GPR41, GPR43). These two receptors are important regulatory receptors for sugar metabolism and fat metabolism. It plays a role in accelerating metabolism and reducing liver load.
- the supplementation of short-chain fatty acids directly participates in and accelerates the operation of the tricarboxylic acid cycle, promoting the chemical reaction balance of ethanol to produce acetic acid to shift to the right, thus accelerating the metabolism of alcohol.
- the short-chain fatty acids rich in dragon fruit fermentation liquid can also affect blood cholesterol levels, especially propionic acid, which is metabolized by the liver and used as energy after being absorbed through the colon, and can inhibit the synthesis of liver cholesterol. This plays a role in protecting the liver.
- Pueraria lobata extract is extracted from Pueraria lobata. Its main components include puerarin, Pueraria lobata isoflavones, Pueraria lobata total flavonoids, etc. According to “Compendium of Materia Medica”, Pueraria lobata has the effects of clearing away heat and dispelling fire, producing body fluids and quenching thirst, relieving alcohol and soothing the spleen. "Qianjin Prescription” says it “cures drunkenness and insomnia”. It has the functions of promoting cardiovascular and cerebrovascular blood flow, antipyretic and hangover, and enhancing immunity. Modern research shows that Pueraria lobata has certain curative effects on acute alcoholism, and it also has the effects of lowering blood pressure and slowing down the heart rate, and is suitable for the treatment of various patients with acute alcoholism.
- Hovenia dulcis extract Traditional Chinese medicine believes that the seeds of Hovenia truncatula are sweet, neutral and non-toxic. They enter the spleen and stomach meridians and have the effects of relieving alcohol, quenching thirst, and clearing away dampness and heat. Medical scientists of the past dynasties often used it as the main medicine in hangover prescriptions. It is suitable for excessive drinking, drunkenness, dry mouth and frequent thirst. At the same time, modern research has found that the compound formula of Pueraria lobata and Hovenia truncatula can significantly reduce the ethanol concentration in the blood and increase the activity of alcohol metabolizing enzymes.
- B vitamins can help the liver detoxify, help body tissues use oxygen, remove toxins such as alcohol and nicotine, and protect the liver.
- the beneficial effects of the present invention are as follows: it can significantly reduce the ethanol concentration in the blood after drinking, thereby quickly and effectively relieving hangover, and can alleviate various drunken symptoms and hangover feelings. Long-term drinking can improve non-alcoholic symptoms. It has significant effects on fatty liver BMI index, Chinese medicine syndrome and low-density lipoprotein, and also has a good taste.
- Figure 1 is a comparison of changes in blood alcohol content of SD rats after drinking in Experiment 1 of the present invention.
- Figure 2 is a comparison of changes in alcohol concentration of volunteers after drinking in Experiment 2 of the present invention.
- Figure 3 shows the TCM symptom indicators of the two groups at different time points of treatment in Experiment 3 of the present invention.
- FIG. 4 shows the BMI indicators of the two groups at different time points of treatment in Experiment 3 of the present invention.
- Embodiment 1 A hangover-relieving and liver-protecting drink, including the following components by weight: 60 parts of red dragon fruit fermentation stock solution, 30 parts of fructo-oligosaccharides, 20 parts of xylitol, 30 parts of kudzu root extract, and hovenia truncatula extract. 30 parts of food, 0.5*10 -4 parts of nicotinamide, 1.0*10 -6 parts of vitamin B12, 0.5*10 -4 parts of vitamin B6, 0.1*10 -5 parts of folic acid, and 600 parts of water.
- a method for preparing a hangover-relieving and liver-protecting drink of the present invention includes the following steps:
- Step 1 Place the weighed raw materials in the batching tank and homogenize at a temperature of 60°C and a homogenization time of 2 hours;
- Step 2 The homogenized mixed liquid is pumped into the automatic filling equipment, and after filling, the mixture is capped and sealed;
- Step 3 Send the filled and capped finished product into a microwave sterilization equipment for microwave sterilization, cool to normal temperature, then label, spray code, and package to obtain the hangover-relieving and liver-protecting drink of the present invention.
- Embodiment 2 A hangover-relieving and liver-protecting drink, including the following components by weight: 30 parts of red dragon fruit fermentation stock solution, 30 parts of fructooligosaccharides, 30 parts of xylitol, 20 parts of kudzu root extract, and dungeon fruit extract. 20 parts of food, 0.5*10 -4 parts of nicotinamide, 0.5*10 -6 parts of vitamin B12, 0.5*10 -4 parts of vitamin B6, 0.5* 10 -5 parts of folic acid, and 600 parts of water.
- a method for preparing a hangover-relieving and liver-protecting drink of the present invention includes the following steps:
- Step 1 Place the weighed raw materials in the batching tank and homogenize at a temperature of 55°C and a homogenization time of 2 hours;
- Step 2 The homogenized mixed liquid is pumped into the automatic filling equipment, and after filling, the mixture is capped and sealed;
- Step 3 Send the filled and capped finished product into a microwave sterilization equipment for microwave sterilization, cool to normal temperature, then label, spray code, and package to obtain the hangover-relieving and liver-protecting drink of the present invention.
- Embodiment 3 A hangover-relieving and liver-protecting drink, including the following components by weight: 40 parts of red dragon fruit fermentation stock solution, 30 parts of fructo-oligosaccharides, 30 parts of xylitol, 20 parts of kudzu root extract, and hovenia fruit extract. 20 parts of food, 1.0*10 -4 parts of nicotinamide, 1.0*10 -6 parts of vitamin B12, 0.1*10 -4 parts of vitamin B6, 0.1* 10 -5 parts of folic acid, and 600 parts of water.
- a method for preparing a hangover-relieving and liver-protecting drink of the present invention includes the following steps:
- Step 1 Place the weighed raw materials in the batching tank and homogenize at a temperature of 60°C and a homogenization time of 1.5 hours;
- Step 2 The homogenized mixed liquid is pumped into the automatic filling equipment, and after filling, the mixture is capped and sealed;
- Step 3 Send the filled and capped finished product into a microwave sterilization equipment for microwave sterilization, cool to normal temperature, then label, spray code, and package to obtain the hangover-relieving and liver-protecting drink of the present invention.
- Embodiment 4 A hangover-relieving and liver-protecting drink, including the following components by weight: 50 parts of red dragon fruit fermentation stock solution, 50 parts of fructo-oligosaccharide, 30 parts of xylitol, 30 parts of kudzu root extract, and dungeon fruit extract. 30 parts of food, 1.0*10 -4 parts of nicotinamide, 1.0*10 -6 parts of vitamin B12, 0.5*10 -4 parts of vitamin B6, 0.5*10 -5 parts of folic acid, and 800 parts of water.
- a method for preparing a hangover-relieving and liver-protecting drink of the present invention includes the following steps:
- Step 1 Place the weighed raw materials in the batching tank and homogenize at a temperature of 60°C and a homogenization time of 1.5 hours;
- Step 2 The homogenized mixed liquid is pumped into the automatic filling equipment, and after filling, the mixture is capped and sealed;
- Step 3 Send the filled, capped and sealed finished product into a microwave sterilization equipment for microwave sterilization, cool to normal temperature, then label, spray code and package to obtain the hangover-relieving and liver-protecting drink of the present invention.
- Embodiment 5 A hangover-relieving and liver-protecting drink, including the following components by weight: 50 parts of red dragon fruit fermentation stock solution, 60 parts of fructooligosaccharides, 20 parts of xylitol, 20 parts of kudzu root extract, and dungeon fruit extract. 20 parts of food, 1.0*10 -4 parts of nicotinamide, 0.5*10 -6 parts of vitamin B12, 0.1*10 -4 parts of vitamin B6, 0.5*10 -5 parts of folic acid, and 800 parts of water.
- a method for preparing a hangover-relieving and liver-protecting drink of the present invention includes the following steps:
- Step 1 Place the weighed raw materials in the batching tank and homogenize at a temperature of 60°C and a homogenization time of 1.5 hours;
- Step 2 The homogenized mixed liquid is pumped into the automatic filling equipment, and after filling, the mixture is capped and sealed;
- Step 3 Send the filled and capped finished product into a microwave sterilization equipment for microwave sterilization, cool to normal temperature, then label, spray code, and package to obtain the hangover-relieving and liver-protecting drink of the present invention.
- Test animals 30 male SD rats were used in the experiment after general clinical observation and no abnormalities.
- Control group 6 animals, 50% edible alcohol 7g/kg was orally administered, which is equivalent to an adult weighing 70kg drinking 500ml at a time.
- Experimental group A 6 animals, 15 minutes after the 1.5g/kg drink prepared in Example 1 was administered, the same dose of alcohol was administered to the control group.
- Experimental group B 6 animals, 15 minutes after the 1.5g/kg drink prepared in Example 3 was administered, the same dose of alcohol was administered to the control group.
- Experimental group C 6 animals, 15 minutes after 1.5g/kg of the drink prepared in Example 4, the same dose of alcohol as the control group was administered.
- Subject population 30 volunteers, 18 males and 12 females, aged 25 to 50 years old, male weight (80 ⁇ 10) kg, female weight (55 ⁇ 7.5) kg, in good physical condition.
- Experimental group A consists of 10 people, people with outstanding alcohol capacity, that is, people with strong alcohol metabolism ability.
- Experimental group B consists of 10 people with average alcohol capacity, that is, people with average alcohol metabolism ability.
- Experimental group C consists of 10 people, people who are not good at drinking, that is, people with poor ability to metabolize alcohol.
- the experiment was carried out for 3 consecutive days. During the experiment, the volunteers' work, rest and eating habits must be consistent.
- the human breath ethanol content was measured at different time periods of 0.25h, 0.5h, 0.75h, 1h, 1.5h, and 2h after the volunteers drank alcohol. It was found that experimental groups B and C were average drinkers. For people who are not good at drinking alcohol, the alcohol concentration of the subjects within 2 hours after drinking the hangover drink of Example 1 of the present invention was significantly lower than that of the blank group. In experimental group A, that is, the group of people who drink a lot, the ethanol content in human breath and body sensation after drinking have also been reduced to a certain extent. According to the somatosensory feedback of the subjects, the present invention also has obvious effects on dizziness, vomiting and hangover in people with average alcohol consumption and those who are not good at drinking, but has no obvious effect on people with excessive alcohol consumption.
- Subject population This trial collected 30 patients who were treated with diet and exercise from December 2018 to June 2019, and 30 patients who took pitaya fermented puree anti-hangover and liver-protecting drink for comparison.
- Treatment method The treatment course of both groups lasted for 3 months.
- the treatment group took dragon fruit fermented puree to relieve hangover and protect the liver.
- the control group was treated with a diet plan and a reasonable exercise program.
- TCM syndromes before and after treatment (chest and hypochondriac pain, epigastric and abdominal pain, fatigue, loose stools, dry mouth and bitter mouth, restlessness, bowel sounds, noisy pantothenic acid, dry stools, tongue coating, pulse condition);
- LDL-C Low-density lipoprotein cholesterol
- Routine examinations of liver and kidney function and hematuria were conducted before and after drinking the dragon fruit fermented puree anti-hangover and liver-protecting drink, and various adverse reactions were recorded in a timely manner.
- Measurement data parameters are expressed as (x ⁇ s), and t test is used; count data uses Ridit analysis and chi-square test (when 1 ⁇ T ⁇ 5, continuity correction is used; when T ⁇ 1, exact probability test method is used).
- Dragon fruit fermented puree hangover and liver protection drink is a red dragon fruit pulp that has been fermented by yeast, acetic acid bacteria, and lactic acid bacteria for 3 years or more, and is rich in 11 kinds of short-chain fatty acids, water-soluble dietary fiber, enzymes, and enzymatic substances. Nutrients such as anthocyanins can accelerate the tricarboxylic acid cycle and balance the three basic metabolisms of sugar, fat and protein.
- the improvement of traditional Chinese medicine syndrome, BMI index and low-density lipoprotein of patients who took dragon fruit fermented puree anti-hangover and liver-protecting drink were statistically better than that of the control group. For patients with non-alcoholic fat, the improvement of traditional Chinese medicine syndrome, BMI was better than that of the control group. It has a better effect on improving the index and low-density lipoprotein.
Abstract
一种解酒护肝饮品及其制备方法,包括如下重量份的组分:红心火龙果发酵原液30~60份、低聚果糖30~60份、木糖醇20~30份、葛根提取物20~30份、枳椇子提取物20~30份、烟酰胺0.5×10 -4~1.0×10 -4份、维生素B12 0.5×10 -6 ~1.0×10 -6份、维生素B6 0.1×10 -4~0.5×10 -4份、叶酸0.1×10 -5~0.5×10 -5份、水600~800份。制备方法包括均质、灌装、微波杀菌、冷却、贴标、喷码、包装。
Description
本发明属于功能性食品技术领域,尤其涉及一种解酒护肝饮品及其制备方法。
中国制酒历史源远流长,酒文化盛行。随着经济水平的提高,社交应酬、家庭聚会、朋友聚会等,都离不开酒。而且,随着人们酿酒技术的不断成熟,当今的酒早已不再是古代的浊酒,喝不了多少就已经醉得不轻,中医认为适量饮酒对身体有益,能提振精神,也可以舒筋活血,但是,过量饮酒会给身体带来不适,影响身体健康。
现代社会人们压力越来越大,导致情绪过度紧张或抑郁引起肝郁等亚健康,还因饮食不节,长期或大量饮酒导致肝损伤,肝脏是人体最重要器官之一,保持其功能的正常是人体维持健康主要指标。
世界卫生组织指出,酒精中毒仍然是当今世界范围内的公害之一,饮酒过度现象以及由酒精所引发的疾病和问题也日益增多,且进入体内的乙醇大部分经肝脏代谢,对肝脏具有较强的毒性,例如使肝细胞膜表面的脂质过氧化以及破坏肝细胞膜,长期饮酒还会使肝细胞内的微管和线粒体等结构受到破坏,使细胞内的代谢紊乱,产生具有细胞毒性的代谢产物,导致肝细胞肿胀、坏死等等。
目前,市场现有用于调节人体酒精代谢机能的饮料大多都是单一方面调节机能,存在调节功效不够全面的问题,同时具有解酒、护肝的功能性产品,对饮酒人士的健康是非常重要的。
针对上述情况,为克服现有技术的缺陷,本发明的目的在于提供一种有助于加速人体酒精代谢,保护肝脏的火龙果发酵解酒饮品的制备方法,本款饮品以火龙果发酵液为主要作用,搭配药食同源食品配葛根枳椇子提取物及复合营养强化物作为辅助成分起到协同增效的作用,解酒效果明显,护肝功效好,还可以调节自身代谢功能。
本发明采用的技术方案如下:红心火龙果发酵原液30~60份、低聚果糖30~60份、木糖醇20~30份、葛根提取物20~30份、枳椇子提取物20~30份、烟酰胺0.5*10
-4~1.0*10
-4份、维生素B12 0.5*10
-6 ~1.0*10
-6份、维生素B6 0.1*10
-4~0.5*10
-4份、叶酸0.1*10
-5~0.5*10
-5份、水600~800份。
进一步地,本发明一种解酒护肝饮品的制备方法,包括如下步骤:
步骤一:按重量称取对应组分的原料,将称取的原料置于配料罐中均质,得均质后的混合液;
步骤二:均质后的混合液泵入自动灌装设备中,灌装后轧盖密封,得灌装后轧盖密封的成品;
步骤三:将灌装后轧盖密封的成品送入微波杀菌设备中微波杀菌,冷却至常温后贴标、喷码、包装既得一种解酒护肝饮品。
进一步地,所述步骤一中均质时的温度为55~60℃,均质时间为1.5~2h。
进一步地,所述红心火龙果发酵原液的制备方法的授权公告号为CN108402454B。
上述配伍的作用机理如下:
众所周知,三羧酸循环是需氧生物体内普遍存在的代谢途径,分布在线粒体,是三大营养素糖类、脂类、氨基酸最终的代谢通路,对生物体具有重要的生理意义。研究发现柠檬酸、琥珀酸、苹果酸、丙酮酸等多种短链脂肪酸是三羧酸循环中的过程物质,直接参与并加速三羧酸循环的运转,从而提高机体的基础代谢能力,起到加速酒精代谢的作用。
研究表明,目前已发现的仅有的2种特异性短链脂肪酸受体是GPR41和GPR43。这两种受体作为糖代谢、脂肪代谢的重要调节受体,已经成为一个重要的药物筛选靶点。作为脂肪代谢重要器官之一的肝脏常常超负荷运转,火龙果发酵液中富含的乙酸、丙酸、丁酸、戊酸等多种短链脂肪酸能激活GPR41和GPR43受体,从而减轻肝功能负荷,起到护肝的作用。
所述红心火龙果发酵原液的制备方法已申请专利,授权公告号:CN108402454B。火龙果发酵原液中富含多种短链脂肪酸,可以激活FFA2R、FFA3R(GPR41、GPR43)等特异性G蛋白偶联受体,这2种受体是作为糖代谢、脂肪代谢的重要调节受体起到加速代谢、减轻肝负荷的作用。并且短链脂肪酸的补充直接参与并加速三羧酸循环的运转,促进乙醇生成乙酸的化学反应平衡向右移动,从而加速酒精的代谢。火龙果发酵原液中富含的短链脂肪酸还能够影响血液胆固醇水平,尤其是丙酸,经结肠吸收以后由肝脏代谢用作能源,并可以抑制肝胆固醇的合成。从而起到护肝的作用。
葛根提取物,由葛根提取而来,其主要成分有葛根素、葛根异黄酮、葛根总黄酮等。据《本草纲目》载,葛根具清热祛火,生津止渴,解酒醒脾等作用。《千金方》言“治酒醉不醒”。具有促进心脑血管血液流动、解热解酒、增强免疫力等功能。而现代研究表明葛根对急性酒精中毒有一定的疗效,并兼有降低血压、减慢心率的作用,适用于各种急性酒精中毒病人的治疗。
枳椇子提取物。中医认为,枳椇子甘、性平、无毒,入脾、胃经,具解酒止渴、清湿热之效。历代医学家常把它用在解酒方中作为主药,适用于饮酒过量、酒醉不醒、口干频渴。同时现代研究发现葛根、枳椇子复方能够显著降低血液中的乙醇浓度,提高酒精代谢酶的活性。
B族维生素具有帮助肝脏解毒及帮助身体组织利用氧气、解除酒精和尼古丁等毒素,保护肝脏等作用。
采用上述技术方案后,本发明有益效果如下:能显著降低酒后血液中的乙醇浓度,从而能够快速有效地解酒,并能缓解各酒后症状及宿醉感,长期饮用对改善非酒精性脂肪肝BMI指数、中医证候及低密度脂蛋白有显著效果,同时具有良好的口感。
为了更清楚地说明本发明实施例的技术方案,下面将对实施例中所需要使用的附图作简单地介绍,应当理解,以下附图仅示出了本发明的某些实施例,因此不应被看作是对范围的限定,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他相关的附图。
图1为本发明实验1中SD大鼠酒后血液酒精含量变化对比。
图2为本发明实验2中志愿者酒后酒精浓度变化对比。
图3为本发明实验3中两组治疗不同时间点的中医症候指标。
图4为本发明实验3中两组治疗不同时间点的BMI指标。
下面对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例;基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1:一种解酒护肝饮品,包括如下重量份的组分:红心火龙果发酵原液60份、低聚果糖30份、木糖醇20份、葛根提取物30份、枳椇子提取物30份、烟酰胺0.5*10
-4份、维生素B12 1.0*10
-6份、维生素B6 0.5*10
-4份、叶酸0.1*10
-5份、水600份。
本发明一种解酒护肝饮品的制备方法,包括如下步骤:
步骤一:将称取的原料置于配料罐中均质,温度为60℃,均质时间为2h;
步骤二:均质后的混合液泵入自动灌装设备中,灌装后轧盖密封;
步骤三:将灌装后轧盖密封的成品送入微波杀菌设备中微波杀菌,冷却至常温后贴标、喷码、包装制得本发明所述一种解酒护肝饮品。
实施例2:一种解酒护肝饮品,包括如下重量份的组分:红心火龙果发酵原液30份、低聚果糖30份、木糖醇30份、葛根提取物20份、枳椇子提取物20份、烟酰胺0.5*10
-4份、维生素B12 0.5*10
-6份、维生素B6 0.5*10
-4份、叶酸0.5*10
-5份、水600份。
本发明一种解酒护肝饮品的制备方法,包括如下步骤:
步骤一:将称取的原料置于配料罐中均质,温度为55℃,均质时间为2h;
步骤二:均质后的混合液泵入自动灌装设备中,灌装后轧盖密封;
步骤三:将灌装后轧盖密封的成品送入微波杀菌设备中微波杀菌,冷却至常温后贴标、喷码、包装制得本发明所述一种解酒护肝饮品。
实施例3:一种解酒护肝饮品,包括如下重量份的组分:红心火龙果发酵原液40份、低聚果糖30份、木糖醇30份、葛根提取物20份、枳椇子提取物20份、烟酰胺1.0*10
-4份、维生素B12 1.0*10
-6份、维生素B6 0.1*10
-4份、叶酸0.1*10
-5份、水600份。
本发明一种解酒护肝饮品的制备方法,包括如下步骤:
步骤一:将称取的原料置于配料罐中均质,温度为60℃,均质时间为1.5h;
步骤二:均质后的混合液泵入自动灌装设备中,灌装后轧盖密封;
步骤三:将灌装后轧盖密封的成品送入微波杀菌设备中微波杀菌,冷却至常温后贴标、喷码、包装制得本发明所述一种解酒护肝饮品。
实施例4:一种解酒护肝饮品,包括如下重量份的组分:红心火龙果发酵原液50份、低聚果糖50份、木糖醇30份、葛根提取物30份、枳椇子提取物30份、烟酰胺1.0*10
-4份、维生素B12 1.0*10
-6份、维生素B6 0.5*10
-4份、叶酸0.5*10
-5份、水800份。
本发明一种解酒护肝饮品的制备方法,包括如下步骤:
步骤一:将称取的原料置于配料罐中均质,温度为60℃,均质时间为1.5h;
步骤二:均质后的混合液泵入自动灌装设备中,灌装后轧盖密封;
步骤三:将灌装后轧盖密封的成品送入微波杀菌设备中微波杀菌,冷却至常温后贴标、喷码、包装制得本发明所述一种解酒护肝饮品。
实施例5:一种解酒护肝饮品,包括如下重量份的组分:红心火龙果发酵原液50份、低聚果糖60份、木糖醇20份、葛根提取物20份、枳椇子提取物20份、烟酰胺1.0*10
-4份、维生素B12 0.5*10
-6份、维生素B6 0.1*10
-4份、叶酸0.5*10
-5份、水800份。
本发明一种解酒护肝饮品的制备方法,包括如下步骤:
步骤一:将称取的原料置于配料罐中均质,温度为60℃,均质时间为1.5h;
步骤二:均质后的混合液泵入自动灌装设备中,灌装后轧盖密封;
步骤三:将灌装后轧盖密封的成品送入微波杀菌设备中微波杀菌,冷却至常温后贴标、喷码、包装制得本发明所述一种解酒护肝饮品。
以下为产品的功效评价实验:
实验1-SD大鼠酒后血液乙醇代谢
受试动物:雄性SD大鼠30只,经一般临床观察无异常后用于实验。
实验分组
对照组:6只,灌胃50%食用酒精7g/kg,相当于70kg体重成人一次饮用500ml。
实验组A:6只,灌胃实例1制备饮品1.5g/kg后15min,灌胃对照组相同剂量酒精。
实验组B:6只,灌胃实例3制备饮品1.5g/kg后15min,灌胃对照组相同剂量酒精。
实验组C:6只,灌胃实例4制备饮品1.5g/kg后15min,灌胃对照组相同剂量酒精。
实验方法
各组分别灌胃50%食用酒精7g/kg后按实验组别要求剂量灌胃供试品。每组分别于给予酒精后0.25h、0.5h、1h、2h、6h,采集血液,检测血液中乙醇浓度。数据统计
采用Phoenix® WinNonlin® 8.2统计软件,线性梯形线性插值法(Linear Trapezoidal Linear Interpolation rule)进行分析,检验水平α=0 .05。
实验结果
检测结果如下表1所示
注:*表示与对照组比较P<0.05(表示与对照组比较具有显著性差异);
上述实验结果表明本发明所述的火龙果发酵原浆解酒护肝饮品具有显著的促进酒精代谢的作用。实验组A、B、C即实例1、3、4与对照组相比饮酒后6h内酒精代谢速率有显著提升。
实验2-人体酒后呼气及体感比较
受试人群:志愿者30人,18男、12女,年龄25~50岁,男性体重(80±10)kg,女性体重(55±7.5)kg,身体状况良好。
市售52°茅台(酱香型)、市售 兆为酒精测试仪检测仪黑猫3号
实验方法
实验组A 10人,酒量出众即酒精代谢能力强的人群。
实验组B 10人,酒量一般即酒精代谢能力普通人群。
实验组C 10人,不善饮酒即酒精代谢能力差的人群。
实验连续进行3天。实验期间受试志愿者作息及饮食规律需保持一致。
实验第一天,正常作息,以当天作息及饮食作为之后3天模板。
实验第二天,午餐后禁食6h,空腹饮酒100ml,分别于15min、30min、45min、60min、90min、120min进行酒精吹气检测,记录实验期间体感状态。
实验第三天,午餐后禁食6h,空腹饮用本发明所述的火龙果发酵原浆解酒护肝饮品实例1 100ml,15min后饮酒100ml,分别于15min、30min、45min、60min、90min、120min进行酒精吹气检测,记录实验期间体感状态。
实验结果
检测结果如下表2所示
注:*表示与对照组比较P<0.05(表示与空白组比较具有显著性差异);**表示与对照组比较P<0.01(表示与空白组比较具有极其显著性差异);
从表2的结果可以看出,对志愿者酒后0.25h,0.5h,0.75h,1h,1.5h,2h不同时间段内进行人体呼气乙醇含量测定,发现实验组B、C即酒量普通及不善饮酒人群服用本发明实施例1解酒饮品后受试者酒后2h内酒精浓度比空白组有了明显下降。而实验组A即酒量出众的人群酒后人体呼气乙醇含量和体感也有一定减轻。而根据受试者体感反馈,同样本发明对酒量普通及不善饮酒人群晕眩感、呕吐感及宿醉感效果明显,但对于酒量出众的人群效果不显。
上述实验结果可以证明本发明的火龙果发酵原浆解酒护肝饮品对于酒精代谢能力普通或代谢能力有缺陷的人群能起到加速酒精代谢的积极作用。
实验3-火龙果发酵原浆解酒护肝饮品治疗非酒精性脂肪肝的临床疗效观察
受试人群:本试验收集2018年12月到2019年6月间采用饮食运动治疗患者30例,服用火龙果发酵原浆解酒护肝饮品患者30例进行对照。
治疗方法:两组疗程均为3月,治疗组服用火龙果发酵原浆解酒护肝饮品。对照组采用饮食计划及合理运动方案治疗。
观察项目与检测方法:
治疗前后中医证候(胸胁胀痛、脘腹胀痛、乏力、便溏不爽、口干口苦、善太息、肠鸣矢气、嘈杂泛酸、大便干、舌苔、脉象)改善情况;
BMI指数;
低密度脂蛋白胆固醇(LDL-C)。
安全性及不良反应:
分别于饮用火龙果发酵原浆解酒护肝饮品前后进行肝、肾功能及血尿常规检查,并及时记录各种不良反应。
用SPSS14.0统计软件进行统计学处理。计量资料参数以(x士s)表示,采用t检验;计数资料采用Ridit分析及卡方检验(1≤T≤5时,采用连续性校正;T<1时,采用精确概率检验法)。
实验结果
实验结果显示与图3、图4。火龙果发酵原浆解酒护肝饮品为红心火龙果果肉经酵母菌、醋酸菌、乳酸菌经历发酵3年及以上,得到富含11种短链脂肪酸、水溶性膳食纤维、酶及酶促物质、花青素等营养物质,能够加速三羧酸循环运转,平衡糖、脂肪及蛋白质三大基础代谢等多种功效。服用火龙果发酵原浆解酒护肝饮品患者的中医症证候、BMI指数以及低密度的脂蛋白改善情况从数据上看优于对照组,对非酒精性脂肪患者在中医症证候、BMI指数以及低密度的脂蛋白方面有较好的改善作用。
需要说明的是,在本文中,诸如第一和第二等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来,而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。而且,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
以上对本发明及其实施方式进行了描述,这种描述没有限制性,实际的结构并不局限于此。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护范围。
Claims (3)
- 一种解酒护肝饮品,其特征在于:包括如下重量份的组分:红心火龙果发酵原液30~60份、低聚果糖30~60份、木糖醇20~30份、葛根提取物20~30份、枳椇子提取物20~30份、烟酰胺0.5*10 -4~1.0*10 -4份、维生素B12 0.5*10 -6 ~1.0*10 -6份、维生素B6 0.1*10 -4~0.5*10 -4份、叶酸0.1*10 -5~0.5*10 -5份、水600~800份。
- 一种解酒护肝饮品的制备方法,其特征在于:包括如下步骤:步骤一:按重量称取对应组分的原料,将称取的原料置于配料罐中均质,得均质后的混合液;步骤二:均质后的混合液泵入自动灌装设备中,灌装后轧盖密封,得灌装后轧盖密封的成品;步骤三:将灌装后轧盖密封的成品送入微波杀菌设备中微波杀菌,冷却至常温后贴标、喷码、包装既得一种解酒护肝饮品。
- 根据权利要求2所述的一种解酒护肝饮品的制备方法,其特征在于:所述步骤一中均质时的温度为55~60℃,均质时间为1.5~2h。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211129921.9 | 2022-09-16 | ||
CN202211129921.9A CN115517325A (zh) | 2022-09-16 | 2022-09-16 | 一种解酒护肝饮品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024055835A1 true WO2024055835A1 (zh) | 2024-03-21 |
Family
ID=84697982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2023/115306 WO2024055835A1 (zh) | 2022-09-16 | 2023-08-28 | 一种解酒护肝饮品及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115517325A (zh) |
WO (1) | WO2024055835A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115517325A (zh) * | 2022-09-16 | 2022-12-27 | 上海合庆火龙果科技开发有限公司 | 一种解酒护肝饮品及其制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101766715A (zh) * | 2008-12-31 | 2010-07-07 | 克科 | 解酒醒酒组合物 |
CN103815490A (zh) * | 2014-03-10 | 2014-05-28 | 尹海日 | 一种饮酒前后饮用的护肝胃解酒饮品及其制备方法 |
CN105639525A (zh) * | 2016-02-03 | 2016-06-08 | 大管家(上海)健康产业有限公司 | 护肝排毒果蔬酵素及其制备方法 |
CN106962924A (zh) * | 2017-03-29 | 2017-07-21 | 贵州穗蓝酒业科技有限公司 | 一种能醒酒的组合物及其制备方法 |
CN108402454A (zh) * | 2018-02-24 | 2018-08-17 | 上海合庆火龙果科技开发有限公司 | 红心火龙果酵素、制备方法及其应用 |
CN110447796A (zh) * | 2019-07-28 | 2019-11-15 | 昆明科晔生物技术有限公司 | 一种醒酒护肝的饮料及其制备方法 |
CN112369489A (zh) * | 2020-11-17 | 2021-02-19 | 蚌埠学院 | 一种葛根火龙果降血脂解酒保健软糖及其制备方法 |
CN115517325A (zh) * | 2022-09-16 | 2022-12-27 | 上海合庆火龙果科技开发有限公司 | 一种解酒护肝饮品及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107048122A (zh) * | 2017-04-19 | 2017-08-18 | 广西大学 | 一种能解酒护肝的枳椇子保健饮料及其制备方法 |
CN108402453A (zh) * | 2018-02-24 | 2018-08-17 | 上海合庆火龙果科技开发有限公司 | 红心火龙果发酵液、红心火龙果酵素及保健饮品 |
CN109303222A (zh) * | 2018-11-22 | 2019-02-05 | 江苏省农业科学院 | 一种无糖无醇型健康复合酵素饮品的制备方法 |
CN114404545A (zh) * | 2022-03-09 | 2022-04-29 | 四川兰冰生物药业有限公司 | 一种解酒护肝组合物及其制备方法 |
-
2022
- 2022-09-16 CN CN202211129921.9A patent/CN115517325A/zh active Pending
-
2023
- 2023-08-28 WO PCT/CN2023/115306 patent/WO2024055835A1/zh unknown
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101766715A (zh) * | 2008-12-31 | 2010-07-07 | 克科 | 解酒醒酒组合物 |
CN103815490A (zh) * | 2014-03-10 | 2014-05-28 | 尹海日 | 一种饮酒前后饮用的护肝胃解酒饮品及其制备方法 |
CN105639525A (zh) * | 2016-02-03 | 2016-06-08 | 大管家(上海)健康产业有限公司 | 护肝排毒果蔬酵素及其制备方法 |
CN106962924A (zh) * | 2017-03-29 | 2017-07-21 | 贵州穗蓝酒业科技有限公司 | 一种能醒酒的组合物及其制备方法 |
CN108402454A (zh) * | 2018-02-24 | 2018-08-17 | 上海合庆火龙果科技开发有限公司 | 红心火龙果酵素、制备方法及其应用 |
CN110447796A (zh) * | 2019-07-28 | 2019-11-15 | 昆明科晔生物技术有限公司 | 一种醒酒护肝的饮料及其制备方法 |
CN112369489A (zh) * | 2020-11-17 | 2021-02-19 | 蚌埠学院 | 一种葛根火龙果降血脂解酒保健软糖及其制备方法 |
CN115517325A (zh) * | 2022-09-16 | 2022-12-27 | 上海合庆火龙果科技开发有限公司 | 一种解酒护肝饮品及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN115517325A (zh) | 2022-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102934809B (zh) | 益生菌发酵中药制剂制备的组合物及其制备方法和应用 | |
JP5512590B2 (ja) | 二日酔い解消及び予防用組成物とこれを利用した飲酒前後二日酔い解消用飲み物 | |
CN103725469B (zh) | 一种养生干红葡萄酒 | |
WO2024055835A1 (zh) | 一种解酒护肝饮品及其制备方法 | |
KR102107387B1 (ko) | 흑삼 추출물을 함유하는 숙취해소용 음료 조성물 | |
CN103211257B (zh) | 一种降血糖苹果醋保健饮料及其制备方法 | |
CN102511864B (zh) | 一种红枣浓浆 | |
CN103343083A (zh) | 一种护肝解酒果醋及其制备方法 | |
CN107488545A (zh) | 一种新型薏仁米酒及其酿造方法 | |
CN107897604A (zh) | 一种缓解体力疲劳的西洋参饮品制备方法 | |
CN104388236A (zh) | 一种葡萄酒及其制备方法与应用 | |
CN110214874A (zh) | 一种番茄保健饮料、其制备方法及应用 | |
CN103798494A (zh) | 健胃益脾红茶菌山楂糕及其制作方法 | |
CN103238889A (zh) | 一种抗疲劳苹果醋保健饮料及其制备方法 | |
CN103798667B (zh) | 菌茶红枣山楂糕及其制作方法 | |
CN108770971A (zh) | 一种解酒护肝巧克力及其制备方法 | |
CN107439866A (zh) | 枸杞鹰嘴豆植物营养素饮料及其制备工艺 | |
CN113229431A (zh) | 一种白肉灵芝运动饮料及其制备方法 | |
CN106822858A (zh) | 一种具有解酒醒酒、降脂护肝、健脾养胃作用的组合物 | |
CN113424953A (zh) | 一种适合孕妇食用的即食燕窝产品及其制备方法 | |
CN103843902B (zh) | 一种含有葛根的液态乳制品及其制备方法 | |
CN1231856A (zh) | 一种茶菌系列饮料 | |
CN102511860B (zh) | 一种添加植物甾醇适合孕妇食用的红枣浓浆 | |
CN109497228A (zh) | 一种黑糖姜茶及其制备方法 | |
CN115299614B (zh) | 一种解酒组合物、解酒果冻及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23864567 Country of ref document: EP Kind code of ref document: A1 |